Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study

Charlie Strange,1 Joseph Tkacz,2 Jill Schinkel,2 Benjamin Lewing,2 Barnabie Agatep,2 Sean Swisher,3 Sushma Patel,3 Devechio Edwards,3 Daniel R Touchette,4 Edward Portillo,5 Norbert Feigler,3 Michael Pollack3 1College of Medicine, The Medical University of South Carolina, Charleston, SC, USA; 2Data S...

Full description

Bibliographic Details
Main Authors: Strange C, Tkacz J, Schinkel J, Lewing B, Agatep B, Swisher S, Patel S, Edwards D, Touchette DR, Portillo E, Feigler N, Pollack M
Format: Article
Language:English
Published: Dove Medical Press 2023-10-01
Series:International Journal of COPD
Subjects:
copd
triple therapy
exacerbations
delayed therapy
budesonide/glycopyrrolate/ formoterol fumarate
Online Access:https://www.dovepress.com/exacerbations-and-real-world-outcomes-after-single-inhaler-triple-ther-peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/exacerbations-and-real-world-outcomes-after-single-inhaler-triple-ther-peer-reviewed-fulltext-article-COPD

Similar Items